Stride, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Stride, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $238.87M | Aug 8, 2018 |
| FY2018 | Mar 31, 2018 | $232.86M | Aug 8, 2018 |
| FY2018 | Dec 31, 2017 | $217.21M | Aug 8, 2018 |
| FY2018 | Sep 30, 2017 | $228.79M | Aug 8, 2018 |
| FY2018 | Jun 30, 2017 | $215.76M | Aug 8, 2018 |
| FY2018 | Mar 31, 2017 | $222.53M | Aug 8, 2018 |
| FY2018 | Dec 31, 2016 | $221.09M | Aug 8, 2018 |
| FY2018 | Sep 30, 2016 | $229.14M | Aug 8, 2018 |
| FY2017 | Jun 30, 2016 | $221.32M | Aug 9, 2017 |
| FY2017 | Mar 31, 2016 | $221.34M | Aug 9, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.41B | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $2.04B | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $1.84B | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $1.69B | Aug 7, 2024 |
| FY2023 | Jun 30, 2021 | $1.54B | Aug 16, 2023 |
| FY2022 | Jun 30, 2020 | $1.04B | Aug 10, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $943.92M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $763.60M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $647.07M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $596.48M | Aug 7, 2024 |
| FY2023 | Jun 30, 2021 | $534.90M | Aug 16, 2023 |
| FY2020 | Jun 30, 2020 | $91.50M | Aug 12, 2020 |
| FY2020 | Mar 31, 2020 | $78.19M | Aug 12, 2020 |
| FY2020 | Dec 31, 2019 | $90.09M | Aug 12, 2020 |
| FY2020 | Sep 30, 2019 | $87.76M | Aug 12, 2020 |
| FY2020 | Jun 30, 2019 | $80.45M | Aug 12, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $287.94M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $204.18M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $126.87M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $107.13M | Aug 7, 2024 |
| FY2023 | Jun 30, 2021 | $71.45M | Aug 16, 2023 |
| FY2020 | Jun 30, 2020 | $4.89M | Aug 12, 2020 |
| FY2020 | Mar 31, 2020 | $8.75M | Aug 12, 2020 |
| FY2020 | Dec 31, 2019 | $20.59M | Aug 12, 2020 |
| FY2020 | Sep 30, 2019 | ($9.73M) | Aug 12, 2020 |
| FY2020 | Jun 30, 2019 | $3.32M | Aug 12, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $360.09M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $249.60M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $165.50M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $156.63M | Aug 7, 2024 |
| FY2023 | Jun 30, 2021 | $110.46M | Aug 16, 2023 |
| FY2020 | Jun 30, 2020 | $7.04M | Aug 12, 2020 |
| FY2020 | Mar 31, 2020 | $14.50M | Aug 12, 2020 |
| FY2020 | Dec 31, 2019 | $30.31M | Aug 12, 2020 |
| FY2020 | Sep 30, 2019 | ($19.39M) | Aug 12, 2020 |
| FY2020 | Jun 30, 2019 | $2.68M | Aug 12, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $16.60M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $16.70M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $15.50M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $7.50M | Aug 7, 2024 |
| FY2023 | Jun 30, 2021 | $3.70M | Aug 16, 2023 |
| FY2022 | Jun 30, 2020 | $9.70M | Aug 10, 2022 |
| FY2019 | Jun 30, 2019 | $2.56M | Aug 7, 2019 |
| FY2019 | Mar 31, 2019 | $2.34M | Aug 7, 2019 |
| FY2019 | Dec 31, 2018 | $1.07M | Aug 7, 2019 |
| FY2019 | Sep 30, 2018 | $3.50M | Aug 7, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $524.35M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $514.00M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $481.57M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $439.85M | Aug 7, 2024 |
| FY2023 | Jun 30, 2021 | $424.44M | Aug 16, 2023 |
| FY2020 | Jun 30, 2020 | $84.45M | Aug 12, 2020 |
| FY2020 | Mar 31, 2020 | $63.69M | Aug 12, 2020 |
| FY2020 | Dec 31, 2019 | $59.78M | Aug 12, 2020 |
| FY2020 | Sep 30, 2019 | $107.15M | Aug 12, 2020 |
| FY2020 | Jun 30, 2019 | $77.77M | Aug 12, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $432.82M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $278.80M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $203.15M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $206.88M | Aug 7, 2024 |
| FY2023 | Jun 30, 2021 | $134.15M | Aug 16, 2023 |
| FY2022 | Jun 30, 2020 | $80.42M | Aug 10, 2022 |
| FY2021 | Jun 30, 2019 | $141.61M | Aug 11, 2021 |
| FY2020 | Jun 30, 2018 | $105.45M | Aug 12, 2020 |
| FY2019 | Jun 30, 2017 | $88.73M | Aug 7, 2019 |
| FY2018 | Jun 30, 2016 | $121.78M | Aug 8, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.78M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $2.27M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $4.34M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $9.75M | Aug 7, 2024 |
| FY2023 | Jun 30, 2021 | $3.57M | Aug 16, 2023 |
| FY2022 | Jun 30, 2020 | $1.68M | Aug 10, 2022 |
| FY2021 | Jun 30, 2019 | $5.48M | Aug 11, 2021 |
| FY2020 | Jun 30, 2018 | $8.74M | Aug 12, 2020 |
| FY2019 | Jun 30, 2017 | $2.17M | Aug 7, 2019 |
| FY2018 | Jun 30, 2016 | $5.01M | Aug 8, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.29B | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $1.92B | Aug 6, 2025 |
| FY2024 | Jun 30, 2023 | $1.76B | Aug 7, 2024 |
| FY2023 | Jun 30, 2022 | $1.64B | Aug 16, 2023 |
| FY2022 | Jun 30, 2021 | $1.58B | Aug 10, 2022 |
| FY2021 | Jun 30, 2020 | $1.07B | Aug 11, 2021 |
| FY2020 | Jun 30, 2019 | $819.61M | Aug 12, 2020 |
| FY2019 | Jun 30, 2018 | $741.96M | Aug 7, 2019 |
| FY2018 | Jun 30, 2017 | $735.28M | Aug 8, 2018 |
| FY2017 | Jun 30, 2016 | $734.06M | Aug 9, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $814.34M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $744.44M | Aug 6, 2025 |
| FY2024 | Jun 30, 2023 | $813.37M | Aug 7, 2024 |
| FY2023 | Jun 30, 2022 | $830.96M | Aug 16, 2023 |
| FY2022 | Jun 30, 2021 | $772.65M | Aug 10, 2022 |
| FY2021 | Jun 30, 2020 | $397.93M | Aug 11, 2021 |
| FY2020 | Jun 30, 2019 | $186.24M | Aug 12, 2020 |
| FY2019 | Jun 30, 2018 | $154.77M | Aug 7, 2019 |
| FY2018 | Jun 30, 2017 | $160.24M | Aug 8, 2018 |
| FY2017 | Jun 30, 2016 | $167.83M | Aug 9, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.48B | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $1.18B | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $947.30M | Aug 6, 2025 |
| FY2025 | Jun 30, 2022 | $812.58M | Aug 6, 2025 |
| FY2024 | Jun 30, 2021 | $804.65M | Aug 7, 2024 |
| FY2023 | Jun 30, 2020 | $675.33M | Aug 16, 2023 |
| FY2022 | Jun 30, 2019 | $633.37M | Aug 10, 2022 |
| FY2021 | Jun 30, 2018 | $587.19M | Aug 11, 2021 |
| FY2020 | Jun 30, 2017 | $574.35M | Aug 12, 2020 |
| FY2019 | Jun 30, 2016 | $558.72M | Aug 7, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $246.68M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $246.68M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $246.70M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $241.00M | Aug 7, 2024 |
| FY2023 | Jun 30, 2021 | $240.40M | Aug 16, 2023 |
| FY2022 | Jun 30, 2020 | $174.90M | Aug 10, 2022 |
| FY2021 | Jun 30, 2019 | $90.20M | Aug 11, 2021 |
| FY2021 | Jun 30, 2018 | $90.20M | Aug 11, 2021 |
| FY2020 | Jun 30, 2017 | $87.20M | Aug 12, 2020 |
| FY2019 | Jun 30, 2016 | $87.30M | Aug 7, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $846.45M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $558.51M | Aug 6, 2025 |
| FY2024 | Jun 30, 2023 | $354.33M | Aug 7, 2024 |
| FY2023 | Jun 30, 2022 | $227.46M | Aug 16, 2023 |
| FY2022 | Jun 30, 2021 | $112.15M | Aug 10, 2022 |
| FY2021 | Jun 30, 2020 | $46.95M | Aug 11, 2021 |
| FY2020 | Jun 30, 2019 | $22.45M | Aug 12, 2020 |
| FY2019 | Jun 30, 2018 | ($13.43M) | Aug 7, 2019 |
| FY2018 | Jun 30, 2017 | ($40.98M) | Aug 8, 2018 |
| FY2017 | Jun 30, 2016 | ($41.43M) | Aug 9, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $782.50M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $500.61M | Aug 6, 2025 |
| FY2024 | Jun 30, 2023 | $410.81M | Aug 7, 2024 |
| FY2023 | Jun 30, 2022 | $389.40M | Aug 16, 2023 |
| FY2023 | Jun 30, 2021 | $386.08M | Aug 16, 2023 |
| FY2022 | Jun 30, 2020 | $212.30M | Aug 10, 2022 |
| FY2021 | Jun 30, 2019 | $283.12M | Aug 11, 2021 |
| FY2020 | Jun 30, 2018 | $231.11M | Aug 12, 2020 |
| FY2019 | Jun 30, 2017 | $230.86M | Aug 7, 2019 |
| FY2018 | Jun 30, 2016 | $213.99M | Aug 8, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $416.32M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $414.68M | Aug 6, 2025 |
| FY2024 | Jun 30, 2023 | $413.04M | Aug 7, 2024 |
| FY2023 | Jun 30, 2022 | $411.44M | Aug 16, 2023 |
| FY2022 | Jun 30, 2021 | $299.27M | Aug 10, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 6 | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | 4 | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | 3 | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | 2 | Aug 7, 2024 |
| FY2023 | Jun 30, 2021 | 1 | Aug 16, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 12, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 12, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 12, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Aug 12, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 12, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 5 | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | 4 | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | 2 | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | 2 | Aug 7, 2024 |
| FY2023 | Jun 30, 2021 | 1 | Aug 16, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 12, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 12, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 12, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Aug 12, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 12, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 43.52M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | 43.24M | Aug 6, 2025 |
| FY2024 | Jun 30, 2023 | 43.00M | Aug 7, 2024 |
| FY2023 | Jun 30, 2022 | 42.78M | Aug 16, 2023 |
| FY2022 | Jun 30, 2021 | 41.58M | Aug 10, 2022 |
| FY2021 | Jun 30, 2020 | 41.01M | Aug 11, 2021 |
| FY2020 | Jun 30, 2019 | 40.24M | Aug 12, 2020 |
| FY2019 | Jun 30, 2018 | 39.57M | Aug 7, 2019 |
| FY2018 | Jun 30, 2017 | 40.82M | Aug 8, 2018 |
| FY2017 | Jun 30, 2016 | 39.68M | Aug 9, 2017 |